-
Uncategorized1 month ago
FDA’s oncology advisors vote against ‘new paradigm’ in AstraZeneca trial
FDA's oncology advisors vote against 'new paradigm' in AstraZeneca trial
-
Uncategorized1 month ago
Advanced Neural Probes Reveal Predictable Patterns in Epileptic Brain Activity
In addition to suffering seizures, many people with epilepsy also experience bursts of abnormal brain activity called interictal epileptiform discharges (IEDs). These can happen thousands of...
-
Uncategorized1 month ago
Court dismisses part of Lilly lawsuit against Empower, some claims can proceed
Court dismisses part of Lilly lawsuit against Empower, some claims can proceed
-
Uncategorized1 month agoSTAT+: As artificial intelligence show off diagnostic chops, scientists reckon with the way forward
Getting a paper published in Science is a highlight of many researchers’ careers. But for internist and clinical AI researcher Adam Rodman, it’s also been a...
-
Uncategorized1 month ago
MRD as a Decision Engine: Rethinking Oncology Trial Design from Early Phase to Registration
As MRD shifts from prognostic marker to intervention trigger, sponsors must rethink trial design, endpoints and decision-making.
-
Uncategorized1 month ago
Lilly’s weight loss pill reaches brand new patients, even without full-court marketing press
Foundayo became available on April 9 and has already reached 20,000 patients as Eli Lilly builds its marketing machine for the weight loss pill.
-
Uncategorized1 month agoMerck still sees ‘compelling’ outlook for Terns leukemia drug
Despite updated study data that suggest Terns’ treatment may be less differentiated, company executives claimed Thursday that it still could be an important step forward in...
-
Uncategorized1 month agoUniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy
News of the submission, which would be the first for UniQure’s closely watched treatment, comes as the therapy faces an uncertain future in the U.S. Read...
-
Uncategorized1 month ago
Pathogenic Bacterium Rewires Gut Environment to Colonize and Cause Disease
An international research team headed by scientists at Vanderbilt University Medical Center has shown how an intestinal pathogen reshapes the gut environment to fuel its own...
-
Uncategorized1 month ago
Avalyn’s upsized IPO; Alector ends another study in GSK partnership
Avalyn's upsized IPO; Alector ends another study in GSK partnership
